Alfapump

DEVICE6 trials

Sponsors

Sequana Medical N.V., University of Leipzig

Conditions

AscitesHeart FailureLiver CirrhosesLiver CirrhosisMalignant Ascites

Phase 1

Optimal Balance Alfapump® System Feasibility Study

WithdrawnNCT03032211

Sequana Medical N.V.Heart Failure

Start: 2017-12-31End: 2020-12-31Updated: 2021-03-22

Unknown Phase

Alfapump-albumin Replacement Therapy

TerminatedNCT02448160

Sequana Medical N.V.Liver Cirrhosis

Start: 2016-01-31End: 2017-12-31Target: 10Updated: 2018-04-09

Alfapump System Versus Transjugular Intrahepatic Portosystemic Shunt and Paracentesis in the Treatment of Ascites

TerminatedNCT02612519

University of LeipzigLiver Cirrhosis

Start: 2015-11-30End: 2019-04-30Updated: 2019-07-31

Retrospective Study in the Use of the Alfapump and the Treatment of Malignant Ascites

CompletedNCT03200106

Sequana Medical N.V.Malignant Ascites

Start: 2017-08-01End: 2018-03-31Updated: 2018-04-09

Alfapump® System in the Treatment of Refractory or Recurrent Ascites (POSEIDON Study)

Sequana Medical N.V.Ascites

Start: 2019-09-16End: 2024-06-30Updated: 2022-12-01

International Alfapump Cohort Study

Active, not recruitingNCT04326946

Sequana Medical N.V.Liver Cirrhoses, Malignant Ascites

Start: 2018-08-14End: 2030-12-31Target: 400Updated: 2024-11-12

Related Papers

Continuous low flow ascites drainage through the urinary bladder via the Alfapump system in palliative patients with malignant ascites

BMC Palliative Care2019-12-0115 citations

Treatment of refractory ascites with an automated low‐flow ascites pump in patients with cirrhosis

Alimentary Pharmacology & Therapeutics2017-09-2157 citations